IBDEI0KD ; ; 09-AUG-2016
 ;;3.0;IB ENCOUNTER FORM IMP/EXP;;MAY 12, 2016
 Q:'DIFQR(358.3)  F I=1:2 S X=$T(Q+I) Q:X=""  S Y=$E($T(Q+I+1),4,999),X=$E(X,4,999) S:$A(Y)=126 I=I+1,Y=$E(Y,2,999)_$E($T(Q+I+1),5,99) S:$A(Y)=61 Y=$E(Y,2,999) X NO E  S @X=Y
Q Q
 ;;^UTILITY(U,$J,358.3,25786,0)
 ;;=F31.81^^69^1062^23
 ;;^UTILITY(U,$J,358.3,25786,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,25786,1,3,0)
 ;;=3^Bipolar II Disorder
 ;;^UTILITY(U,$J,358.3,25786,1,4,0)
 ;;=4^F31.81
 ;;^UTILITY(U,$J,358.3,25786,2)
 ;;=^5003519
 ;;^UTILITY(U,$J,358.3,25787,0)
 ;;=F34.0^^69^1062^24
 ;;^UTILITY(U,$J,358.3,25787,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,25787,1,3,0)
 ;;=3^Cyclothymic Disorder
 ;;^UTILITY(U,$J,358.3,25787,1,4,0)
 ;;=4^F34.0
 ;;^UTILITY(U,$J,358.3,25787,2)
 ;;=^5003538
 ;;^UTILITY(U,$J,358.3,25788,0)
 ;;=F31.0^^69^1062^20
 ;;^UTILITY(U,$J,358.3,25788,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,25788,1,3,0)
 ;;=3^Bipolar I Disorder,Current/Recent Episode Hypomanic
 ;;^UTILITY(U,$J,358.3,25788,1,4,0)
 ;;=4^F31.0
 ;;^UTILITY(U,$J,358.3,25788,2)
 ;;=^5003494
 ;;^UTILITY(U,$J,358.3,25789,0)
 ;;=F31.71^^69^1062^22
 ;;^UTILITY(U,$J,358.3,25789,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,25789,1,3,0)
 ;;=3^Bipolar I Disorder,Current/Recent Episode Hypomanic,In Partial Remission
 ;;^UTILITY(U,$J,358.3,25789,1,4,0)
 ;;=4^F31.71
 ;;^UTILITY(U,$J,358.3,25789,2)
 ;;=^5003511
 ;;^UTILITY(U,$J,358.3,25790,0)
 ;;=F31.72^^69^1062^21
 ;;^UTILITY(U,$J,358.3,25790,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,25790,1,3,0)
 ;;=3^Bipolar I Disorder,Current/Recent Episode Hypomanic,In Full Remission
 ;;^UTILITY(U,$J,358.3,25790,1,4,0)
 ;;=4^F31.72
 ;;^UTILITY(U,$J,358.3,25790,2)
 ;;=^5003512
 ;;^UTILITY(U,$J,358.3,25791,0)
 ;;=F06.33^^69^1062^3
 ;;^UTILITY(U,$J,358.3,25791,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,25791,1,3,0)
 ;;=3^Bipolar & Related Disorder d/t Med Cond w/ Manic/Hypomanic-Like Episode
 ;;^UTILITY(U,$J,358.3,25791,1,4,0)
 ;;=4^F06.33
 ;;^UTILITY(U,$J,358.3,25791,2)
 ;;=^5003059
 ;;^UTILITY(U,$J,358.3,25792,0)
 ;;=F31.9^^69^1062^12
 ;;^UTILITY(U,$J,358.3,25792,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,25792,1,3,0)
 ;;=3^Bipolar I Disorder,Current/Recent Episode Manic,Unsp
 ;;^UTILITY(U,$J,358.3,25792,1,4,0)
 ;;=4^F31.9
 ;;^UTILITY(U,$J,358.3,25792,2)
 ;;=^331892
 ;;^UTILITY(U,$J,358.3,25793,0)
 ;;=F31.9^^69^1062^19
 ;;^UTILITY(U,$J,358.3,25793,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,25793,1,3,0)
 ;;=3^Bipolar I Disorder,Current/Recent Episode Depressed,Unsp
 ;;^UTILITY(U,$J,358.3,25793,1,4,0)
 ;;=4^F31.9
 ;;^UTILITY(U,$J,358.3,25793,2)
 ;;=^331892
 ;;^UTILITY(U,$J,358.3,25794,0)
 ;;=F31.89^^69^1062^4
 ;;^UTILITY(U,$J,358.3,25794,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,25794,1,3,0)
 ;;=3^Bipolar & Related Disorder,Other Specified
 ;;^UTILITY(U,$J,358.3,25794,1,4,0)
 ;;=4^F31.89
 ;;^UTILITY(U,$J,358.3,25794,2)
 ;;=^5003520
 ;;^UTILITY(U,$J,358.3,25795,0)
 ;;=F31.9^^69^1062^5
 ;;^UTILITY(U,$J,358.3,25795,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,25795,1,3,0)
 ;;=3^Bipolar & Related Disorder,Unsp
 ;;^UTILITY(U,$J,358.3,25795,1,4,0)
 ;;=4^F31.9
 ;;^UTILITY(U,$J,358.3,25795,2)
 ;;=^331892
 ;;^UTILITY(U,$J,358.3,25796,0)
 ;;=A81.00^^69^1063^8
 ;;^UTILITY(U,$J,358.3,25796,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,25796,1,3,0)
 ;;=3^Creutzfeldt-Jakob Disease,Unspec
 ;;^UTILITY(U,$J,358.3,25796,1,4,0)
 ;;=4^A81.00
 ;;^UTILITY(U,$J,358.3,25796,2)
 ;;=^5000409
 ;;^UTILITY(U,$J,358.3,25797,0)
 ;;=A81.09^^69^1063^7
 ;;^UTILITY(U,$J,358.3,25797,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,25797,1,3,0)
 ;;=3^Creutzfeldt-Jakob Disease,Other
 ;;^UTILITY(U,$J,358.3,25797,1,4,0)
 ;;=4^A81.09
 ;;^UTILITY(U,$J,358.3,25797,2)
 ;;=^5000410
 ;;^UTILITY(U,$J,358.3,25798,0)
 ;;=A81.2^^69^1063^72
 ;;^UTILITY(U,$J,358.3,25798,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,25798,1,3,0)
 ;;=3^Progressive Multifocal Leukoencephalopathy
 ;;^UTILITY(U,$J,358.3,25798,1,4,0)
 ;;=4^A81.2
 ;;^UTILITY(U,$J,358.3,25798,2)
 ;;=^5000411
 ;;^UTILITY(U,$J,358.3,25799,0)
 ;;=F01.50^^69^1063^46
 ;;^UTILITY(U,$J,358.3,25799,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,25799,1,3,0)
 ;;=3^Major Neurocog D/O d/t Prob VASCULAR DISEASE w/o Behav Disturb
 ;;^UTILITY(U,$J,358.3,25799,1,4,0)
 ;;=4^F01.50
 ;;^UTILITY(U,$J,358.3,25799,2)
 ;;=^5003046
 ;;^UTILITY(U,$J,358.3,25800,0)
 ;;=F01.51^^69^1063^47
 ;;^UTILITY(U,$J,358.3,25800,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,25800,1,3,0)
 ;;=3^Major Neurocog D/O d/t Prob VASCULAR DISEASE w/ Behav Disturb
 ;;^UTILITY(U,$J,358.3,25800,1,4,0)
 ;;=4^F01.51
 ;;^UTILITY(U,$J,358.3,25800,2)
 ;;=^5003047
 ;;^UTILITY(U,$J,358.3,25801,0)
 ;;=F02.80^^69^1063^34
 ;;^UTILITY(U,$J,358.3,25801,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,25801,1,3,0)
 ;;=3^Major Neurocog D/O d/t Poss ALZHEIMER'S DISEASE w/o Behav Disturb
 ;;^UTILITY(U,$J,358.3,25801,1,4,0)
 ;;=4^F02.80
 ;;^UTILITY(U,$J,358.3,25801,2)
 ;;=^5003048
 ;;^UTILITY(U,$J,358.3,25802,0)
 ;;=F02.81^^69^1063^35
 ;;^UTILITY(U,$J,358.3,25802,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,25802,1,3,0)
 ;;=3^Major Neurocog D/O d/t Poss ALZHEIMER'S DISEASE w/ Behav Disturb
 ;;^UTILITY(U,$J,358.3,25802,1,4,0)
 ;;=4^F02.81
 ;;^UTILITY(U,$J,358.3,25802,2)
 ;;=^5003049
 ;;^UTILITY(U,$J,358.3,25803,0)
 ;;=G30.9^^69^1063^4
 ;;^UTILITY(U,$J,358.3,25803,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,25803,1,3,0)
 ;;=3^Alzheimer's Disease,Unspec
 ;;^UTILITY(U,$J,358.3,25803,1,4,0)
 ;;=4^G30.9
 ;;^UTILITY(U,$J,358.3,25803,2)
 ;;=^5003808
 ;;^UTILITY(U,$J,358.3,25804,0)
 ;;=G31.01^^69^1063^70
 ;;^UTILITY(U,$J,358.3,25804,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,25804,1,3,0)
 ;;=3^Pick's Disease
 ;;^UTILITY(U,$J,358.3,25804,1,4,0)
 ;;=4^G31.01
 ;;^UTILITY(U,$J,358.3,25804,2)
 ;;=^329915
 ;;^UTILITY(U,$J,358.3,25805,0)
 ;;=G94.^^69^1063^6
 ;;^UTILITY(U,$J,358.3,25805,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,25805,1,3,0)
 ;;=3^Brain Disorders in Diseases Classified Elsewhere NEC
 ;;^UTILITY(U,$J,358.3,25805,1,4,0)
 ;;=4^G94.
 ;;^UTILITY(U,$J,358.3,25805,2)
 ;;=^5004187
 ;;^UTILITY(U,$J,358.3,25806,0)
 ;;=G31.83^^69^1063^18
 ;;^UTILITY(U,$J,358.3,25806,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,25806,1,3,0)
 ;;=3^Dementia w/ Lewy Bodies
 ;;^UTILITY(U,$J,358.3,25806,1,4,0)
 ;;=4^G31.83
 ;;^UTILITY(U,$J,358.3,25806,2)
 ;;=^329888
 ;;^UTILITY(U,$J,358.3,25807,0)
 ;;=G31.89^^69^1063^11
 ;;^UTILITY(U,$J,358.3,25807,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,25807,1,3,0)
 ;;=3^Degenerative Diseases of Nervous System NEC
 ;;^UTILITY(U,$J,358.3,25807,1,4,0)
 ;;=4^G31.89
 ;;^UTILITY(U,$J,358.3,25807,2)
 ;;=^5003814
 ;;^UTILITY(U,$J,358.3,25808,0)
 ;;=G31.9^^69^1063^12
 ;;^UTILITY(U,$J,358.3,25808,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,25808,1,3,0)
 ;;=3^Degenerative Diseases of Nervous System,Unspec
 ;;^UTILITY(U,$J,358.3,25808,1,4,0)
 ;;=4^G31.9
 ;;^UTILITY(U,$J,358.3,25808,2)
 ;;=^5003815
 ;;^UTILITY(U,$J,358.3,25809,0)
 ;;=G23.8^^69^1063^10
 ;;^UTILITY(U,$J,358.3,25809,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,25809,1,3,0)
 ;;=3^Degenerative Diseases of Basal Ganglia NEC
 ;;^UTILITY(U,$J,358.3,25809,1,4,0)
 ;;=4^G23.8
 ;;^UTILITY(U,$J,358.3,25809,2)
 ;;=^5003782
 ;;^UTILITY(U,$J,358.3,25810,0)
 ;;=G30.0^^69^1063^2
 ;;^UTILITY(U,$J,358.3,25810,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,25810,1,3,0)
 ;;=3^Alzheimer's Disease w/ Early Onset
 ;;^UTILITY(U,$J,358.3,25810,1,4,0)
 ;;=4^G30.0
 ;;^UTILITY(U,$J,358.3,25810,2)
 ;;=^5003805
 ;;^UTILITY(U,$J,358.3,25811,0)
 ;;=G30.1^^69^1063^3
 ;;^UTILITY(U,$J,358.3,25811,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,25811,1,3,0)
 ;;=3^Alzheimer's Disease w/ Late Onset
 ;;^UTILITY(U,$J,358.3,25811,1,4,0)
 ;;=4^G30.1
 ;;^UTILITY(U,$J,358.3,25811,2)
 ;;=^5003806
 ;;^UTILITY(U,$J,358.3,25812,0)
 ;;=B20.^^69^1063^21
 ;;^UTILITY(U,$J,358.3,25812,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,25812,1,3,0)
 ;;=3^HIV Infection
 ;;^UTILITY(U,$J,358.3,25812,1,4,0)
 ;;=4^B20.
 ;;^UTILITY(U,$J,358.3,25812,2)
 ;;=^5000555^
 ;;^UTILITY(U,$J,358.3,25813,0)
 ;;=G10.^^69^1063^22
 ;;^UTILITY(U,$J,358.3,25813,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,25813,1,3,0)
 ;;=3^Huntington's Disease
 ;;^UTILITY(U,$J,358.3,25813,1,4,0)
 ;;=4^G10.
 ;;^UTILITY(U,$J,358.3,25813,2)
 ;;=^5003751^
 ;;^UTILITY(U,$J,358.3,25814,0)
 ;;=G30.8^^69^1063^1
 ;;^UTILITY(U,$J,358.3,25814,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,25814,1,3,0)
 ;;=3^Alzheimer's Disease NEC
 ;;^UTILITY(U,$J,358.3,25814,1,4,0)
 ;;=4^G30.8
 ;;^UTILITY(U,$J,358.3,25814,2)
 ;;=^5003807
 ;;^UTILITY(U,$J,358.3,25815,0)
 ;;=A81.89^^69^1063^5
 ;;^UTILITY(U,$J,358.3,25815,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,25815,1,3,0)
 ;;=3^Atypical Virus Infections of CNS NEC
 ;;^UTILITY(U,$J,358.3,25815,1,4,0)
 ;;=4^A81.89
 ;;^UTILITY(U,$J,358.3,25815,2)
 ;;=^5000413
 ;;^UTILITY(U,$J,358.3,25816,0)
 ;;=G20.^^69^1063^69
 ;;^UTILITY(U,$J,358.3,25816,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,25816,1,3,0)
 ;;=3^Parkinson's Disease
 ;;^UTILITY(U,$J,358.3,25816,1,4,0)
 ;;=4^G20.
 ;;^UTILITY(U,$J,358.3,25816,2)
 ;;=^5003770^
 ;;^UTILITY(U,$J,358.3,25817,0)
 ;;=G23.1^^69^1063^73
 ;;^UTILITY(U,$J,358.3,25817,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,25817,1,3,0)
 ;;=3^Progressive Supranuclear Ophthalmoplegia Palsy
 ;;^UTILITY(U,$J,358.3,25817,1,4,0)
 ;;=4^G23.1
 ;;^UTILITY(U,$J,358.3,25817,2)
 ;;=^5003780
 ;;^UTILITY(U,$J,358.3,25818,0)
 ;;=F03.91^^69^1063^17
 ;;^UTILITY(U,$J,358.3,25818,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,25818,1,3,0)
 ;;=3^Dementia w/ Behavioral Disturbance,Unspec
 ;;^UTILITY(U,$J,358.3,25818,1,4,0)
 ;;=4^F03.91
 ;;^UTILITY(U,$J,358.3,25818,2)
 ;;=^5133350
 ;;^UTILITY(U,$J,358.3,25819,0)
 ;;=F03.90^^69^1063^19
 ;;^UTILITY(U,$J,358.3,25819,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,25819,1,3,0)
 ;;=3^Dementia w/o Behavioral Disturbance,Unspec
 ;;^UTILITY(U,$J,358.3,25819,1,4,0)
 ;;=4^F03.90
 ;;^UTILITY(U,$J,358.3,25819,2)
 ;;=^5003050
 ;;^UTILITY(U,$J,358.3,25820,0)
 ;;=F02.81^^69^1063^40
 ;;^UTILITY(U,$J,358.3,25820,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,25820,1,3,0)
 ;;=3^Major Neurocog D/O d/t Prob ALZHEIMER'S DISEASE w/ Behav Disturb
